On March 26, 2026, the European Court of Justice (ECJ) issued a significant and precedent-setting judgment, LF v Sanofi Pasteur SA, reshaping the liability landscape for defective products in the pharmaceutical sector.
Although the case concerned a medicinal product (a vaccine), the Court’s reasoning extends in practice to medical device manufacturers, even
Register for free to keep reading
To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.
- Unlimited access to industry insights
- Stay on top of key rules and regulatory changes with our Rules Navigator
- Ad-free experience with no distractions
- Regular podcasts from trusted external experts
- Fresh compliance and regulatory content every day